Genetic epidemiology of induced CYP3A4 activity

Nilufer Rahmioglu, James Heaton, Gail Clement, Raj Gill, Gabriela Surdulescu, Karolina Zlobecka, Dylan Hodgkiss, Yongmin Ma, Robert C. Hider, Norman W. Smith, Kourosh R. Ahmadi

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)


Aim The cytochrome P450 3A4 (CYP3A4) enzyme is implicated in the metabolism of more than 50% of all prescribed medications and its activity - including induced or inhibited activity - is deemed to be a crucial determinant of interindividual variability in drug disposition, poor therapeutic efficacy, and adverse response to medication. Methods We used the classical twin model in conjunction with an induction experiment to uncover the relative contribution of genetic and environmental factors to interindividual variation in induced CYP3A4 activity. A total of 367 healthy twins participated in the study. Each volunteer was administered a potent inducer of CYP3A4 (St John's Wort) for 14 days and the activity of CYP3A4 was quantified through the metabolism of the exogenously administered probe drug quinine sulfate. Results Baseline and induced CYP3A4 activity were highly variable with a seven-fold and 11-fold difference among our population, respectively. Alcohol consumption, BMI, and smoking were significantly associated with induced CYP3A4 activity, collectively explaining 20% of the variation (P
Original languageEnglish
Pages (from-to)642 - 651
Number of pages10
Issue number10
Publication statusPublished - Oct 2011


Dive into the research topics of 'Genetic epidemiology of induced CYP3A4 activity'. Together they form a unique fingerprint.

Cite this